Acute hand ischemia after intra-arterial injection of meprobamate powder. | Canada Hyperbarics Skip to main content
Clinical Study The Journal of emergency medicine 2012

Acute hand ischemia after intra-arterial injection of meprobamate powder.

Seak CK, Kooi XJ, Seak CJ — The Journal of emergency medicine, 2012

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported a case of acute hand ischemia in a 23-year-old male drug abuser following accidental intra-arterial injection of crushed meprobamate powder.

What They Found

The 23-year-old patient developed gangrene in the distal tips of his right thumb, index, ring, and little fingers despite various medical therapies including heparinization and hyperbaric oxygen. This is believed to be the first documented human case of acute limb ischemia caused by intra-arterial injection of meprobamate powder.

What This Means for Canadian Patients

Canadian patients who inject crushed oral drug formulations are at risk of severe limb ischemia and gangrene. Prompt medical attention is crucial for individuals experiencing symptoms after such injections to potentially mitigate limb-threatening complications.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

As a single case report, the findings are limited in their generalizability to a broader patient population.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Infection
Source Pubmed
PubMed ID 22497894
Year Published 2012
Journal The Journal of emergency medicine
MeSH Terms Acute Disease; Adult; Amputation, Surgical; Anti-Inflammatory Agents; Anticoagulants; Dexamethasone; Dextrans; Drug Users; Hand; Humans; Hyperbaric Oxygenation; Hypnotics and Sedatives; Injections, Intra-Arterial; Ischemia; Male

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.